We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
605 result(s) found, displaying 1 to 10
-
Oct-2025Prescription medicine evaluationActive ingredient: olutasidenib.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ELTROMBOPAG-RZ eltrombopag (as olamine) 50 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ELTROMBOPAG-RZ eltrombopag (as olamine) 25 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ELTROMBOPAG DR.REDDY'S eltrombopag (as olamine) 50 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ELTROMBOPAG DR.REDDY'S eltrombopag (as olamine) 25 mg tablet blister pack.
-
Sep-2025Prescription medicine evaluationActive ingredient: toripalimab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ARX-ABIRATERONE abiraterone acetate 500 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ARX-ABIRATERONE abiraterone acetate 250 mg tablet bottle.
-
Prescription medicine registrationActive ingredients: eltrombopag olamine.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PAZOPANIB-RZ pazopanib (as hydrochloride) 400 mg film coated tablet bottle.